Sandra García‐Mulero

Author

Institut d'Investigació Biomédica de Bellvitge ORCID

Also Known As

S. Garcia-Mulero, S. García-Mulero, Sandra Garcia-Mulero, Sandra García-Mulero, Sandra García‐Mulero

Publications

661

Citations

H-Index

Concepts

All Affiliations

Institut d'Investigació Biomédica de Bellvitge Institut Català d'Oncologia Centro de Investigación Biomédica en Red de Cáncer Universitat de Barcelona Bellvitge University Hospital

About

Sandra García‐Mulero is an author at Institut d'Investigació Biomédica de Bellvitge specializing in tumor biology, immunology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	31
2	Cell Biology	1	1	31
3	Immunology	1	1	31
4	Tumor Biology	1	1	31
5	Cancer Research	1	1	31

Sandra García‐Mulero

Publications

445

Citations

H-Index

Page 1

	Year	Citations
Role of POLE and POLD1 in familial cancer Pilar Mur, Sandra García‐Mulero, Jesús Del Valle, Genetics in Medicine	2020	131
Lung metastases share common immune features regardless of primary tumor origin Sandra García‐Mulero, M. Henar Alonso, Julián Pardo, Journal for ImmunoTherapy of Cancer	2020	111
T-Type Calcium Channels as Potential Therapeutic Targets in Vemurafenib-Resistant BRAFV600E Melanoma Carla Barceló, Pol Sisó, Óscar Maiques, Journal of Investigative Dermatology Tumor BiologyPotential Therapeutic TargetsMedicineMelanomaImmunology	2019	31
High Cysteinyl Leukotriene Receptor 1 Expression Correlates with Poor Survival of Uveal Melanoma Patients and Cognate Antagonist Drugs Modulate the Growth, Cancer Secretome, and Metabolism of Uveal Melanoma Cells Kayleigh Slater, Aisling B. Heeran, Sandra García‐Mulero, Cancers	2020	29
Uveal Melanoma Cell Line Proliferation Is Inhibited by Ricolinostat, a Histone Deacetylase Inhibitor Husvinee Sundaramurthi, Sandra García‐Mulero, Valentina Tonelotto, Cancers	2022	25
TIMP1 Mediates Astrocyte-Dependent Local Immunosuppression in Brain Metastasis Acting on Infiltrating CD8+ T Cells Neibla Priego, Ana de Pablos-Aragoneses, María Perea-García, Cancer Discovery	2024	24
Integrated analysis of circulating immune cellular and soluble mediators reveals specific COVID19 signatures at hospital admission with utility for prediction of clinical outcomes Iratxe Uranga-Murillo, Elena Morte, Sandra Hidalgo, Theranostics	2021	18
Adoptive NK Cell Transfer as a Treatment in Colorectal Cancer Patients: Analyses of Tumour Cell Determinants Correlating With Efficacy In Vitro and In Vivo Pilar M. Lanuza, M. Henar Alonso, Sandra Hidalgo, Frontiers in Immunology	2022	18
Genetic and Immune Changes Associated with Disease Progression under the Pressure of Oncolytic Therapy in A Neuroblastoma Outlier Patient Lídia Franco-Luzón, Sandra García‐Mulero, Rebeca Sanz‐Pamplona, Cancers	2020	17
Recommendations for the classification of germline variants in the exonuclease domain of POLE and POLD1 Pilar Mur, Julen Viana-Errasti, Sandra García‐Mulero, Genome Medicine	2023	17

Page 1